Spyridon Papapetropoulos
Förmögenhet: 145 533 $ per 2026-08-31
Förmögenhet: 145 533 $ per 2026-08-31
Dr. Spyridon Papapetropoulos is a Chief Executive Officer & Executive Director at Neuphoria Therapeutics, Inc., a President, Chief Executive Officer & Director at Bionomics Ltd. and a President at Encephalos Life Sciences LLC.
He is on the Board of Directors at Neuphoria Therapeutics, Inc. and Bionomics Ltd. Dr. Papapetropoulos was previously employed as a Chairman by Lipocine, Inc., an Independent Director by Adamas Pharmaceuticals LLC, a Chief Medical Officer by Vigil Neuroscience, Inc., a Chief Development Officer, SVP & Head-Development by ACADIA Pharmaceuticals, Inc., a Chief Executive Officer by SwanBio Therapeutics, Inc., and a Chief Medical Officer & EVP-R&D by Cavion, Inc. He received his doctorate degree from the University of Patras and a doctorate degree from Semmelweis University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
0,32 % | 2025-04-16 | 5 999 940 ( 0,32 % ) | 124 079 $ | 2026-08-31 |
0,09 % | 2026-09-17 | 4 944 ( 0,09 % ) | 18 589 $ | 2026-08-31 |
LIPOCINE INC 0,02 % | 2025-06-04 | 1 279 ( 0,02 % ) | 2 865 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
Encephalos Life Sciences LLC
Encephalos Life Sciences LLC Miscellaneous Commercial ServicesCommercial Services Operates as a life sciences consulting firm | Grundare | - |
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Verkställande Direktör | 2023-01-05 |
| Företag | Position | Slut |
|---|---|---|
| LIPOCINE INC. | Ordförande | 2026-04-16 |
| VIGIL NEUROSCIENCE, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-01-04 |
| ADAMAS PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2021-11-24 |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders | Verkställande Direktör | 2020-10-01 |
| ACADIA PHARMACEUTICALS INC. | Företagsledare/Principal | 2020-09-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 10 |
|---|---|
ACADIA Pharmaceuticals, Inc.
ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Cavion, Inc.
Cavion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology drugs for solid tumors | Health Technology |
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Health Technology |
University of Patras
University of Patras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Semmelweis University
Semmelweis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lipocine, Inc.
Lipocine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in research and development for the delivery of drugs | Health Technology |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders | Health Technology |
Encephalos Life Sciences LLC
Encephalos Life Sciences LLC Miscellaneous Commercial ServicesCommercial Services Operates as a life sciences consulting firm | Commercial Services |
Vigil Neuroscience, Inc.
Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån